Bobcatbio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $5.34M

  • Investors
  • 9

Bobcatbio General Information

Description

Developer of cancer-specific immunotherapy designed to facilitate the treatment of solid tumors. The company's technology utilizes an adoptive cell therapy approach, macrophage engineering and cryopreservation to provide targeted tumoricidal immune responses, systemic tumor elimination and non-lymphodepleting therapy administration, enabling oncology healthcare providers to improve patient outcomes and reduce reliance on traditional treatments like chemotherapy and radiation.

Contact Information

Formerly Known As
SIRPant Immunotherapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1214 Research Boulevard
  • Suite 2010
  • Hummelstown, PA 17036
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1214 Research Boulevard
  • Suite 2010
  • Hummelstown, PA 17036
  • United States

Bobcatbio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bobcatbio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A1) 25-Feb-2025 $5.34M Completed Clinical Trials - Phase 1
6. Early Stage VC (Series A) 14-Feb-2024 Completed Clinical Trials - Phase 1
5. Grant 01-Jan-2024 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator 01-Sep-2023 Completed Clinical Trials - Phase 1
3. Grant 01-Jul-2022 Completed Clinical Trials - Phase 1
2. Grant 20-Dec-2024 $2.4M Completed Pre-Clinical Trials
1. Grant 22-Sep-2021 $400K Completed Pre-Clinical Trials
To view Bobcatbio’s complete valuation and funding history, request access »

Bobcatbio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A
To view Bobcatbio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bobcatbio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer-specific immunotherapy designed to facilitate the treatment of solid tumors. The company's technolog
Drug Discovery
Hummelstown, PA
7 As of 2026

Auburndale, MA
 

Dublin, OH
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bobcatbio Competitors (6)

One of Bobcatbio’s 6 competitors is Verseau Therapeutics, a Venture Capital-Backed company based in Auburndale, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verseau Therapeutics Venture Capital-Backed Auburndale, MA
Macrophage Therapeutics Corporation Dublin, OH
ALX Oncology Formerly VC-backed South San Francisco, CA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Gilead Formerly VC-backed Foster City, CA
To view Bobcatbio’s complete competitors history, request access »

Bobcatbio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bobcatbio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
NuFund Venture Group Angel Group Minority
GRA Venture Fund Venture Capital Minority
SeedFolio Venture Capital Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
Bios Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Bobcatbio FAQs

  • When was Bobcatbio founded?

    Bobcatbio was founded in 2020.

  • Where is Bobcatbio headquartered?

    Bobcatbio is headquartered in Hummelstown, PA.

  • What is the size of Bobcatbio?

    Bobcatbio has 7 total employees.

  • What industry is Bobcatbio in?

    Bobcatbio’s primary industry is Drug Discovery.

  • Is Bobcatbio a private or public company?

    Bobcatbio is a Private company.

  • What is the current valuation of Bobcatbio?

    The current valuation of Bobcatbio is .

  • What is Bobcatbio’s current revenue?

    The current revenue for Bobcatbio is .

  • How much funding has Bobcatbio raised over time?

    Bobcatbio has raised $32.4M.

  • Who are Bobcatbio’s investors?

    NuFund Venture Group, GRA Venture Fund, SeedFolio, BioAdvance Capital (Conshohocken), and Bios Partners are 5 of 9 investors who have invested in Bobcatbio.

  • Who are Bobcatbio’s competitors?

    Verseau Therapeutics, Macrophage Therapeutics, ALX Oncology, Carisma Therapeutics, and Gilead are some of the 6 competitors of Bobcatbio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process